ATE460930T1 - Zusammensetzung mit acetaminophen, koffein und aspirin zusammen mit einem alkaliwirkstoff für verbesserte absorption - Google Patents

Zusammensetzung mit acetaminophen, koffein und aspirin zusammen mit einem alkaliwirkstoff für verbesserte absorption

Info

Publication number
ATE460930T1
ATE460930T1 AT05821186T AT05821186T ATE460930T1 AT E460930 T1 ATE460930 T1 AT E460930T1 AT 05821186 T AT05821186 T AT 05821186T AT 05821186 T AT05821186 T AT 05821186T AT E460930 T1 ATE460930 T1 AT E460930T1
Authority
AT
Austria
Prior art keywords
acetaminophen
caffeine
composition
improved absorption
alkaline active
Prior art date
Application number
AT05821186T
Other languages
English (en)
Inventor
Rong Liu
Michael Corbo
Jatin Desai
Gerard Frunzi
Xiaohong Qi
Candice Choi
Rahul Gandhi
Atef Boulos
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of ATE460930T1 publication Critical patent/ATE460930T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT05821186T 2004-10-28 2005-10-26 Zusammensetzung mit acetaminophen, koffein und aspirin zusammen mit einem alkaliwirkstoff für verbesserte absorption ATE460930T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62281204P 2004-10-28 2004-10-28
PCT/US2005/038507 WO2006049978A1 (en) 2004-10-28 2005-10-26 Composition comprising acetaminophen, caffeine and optionally aspirin together with an alkiline agent fr enhanced absorption

Publications (1)

Publication Number Publication Date
ATE460930T1 true ATE460930T1 (de) 2010-04-15

Family

ID=35744599

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05821186T ATE460930T1 (de) 2004-10-28 2005-10-26 Zusammensetzung mit acetaminophen, koffein und aspirin zusammen mit einem alkaliwirkstoff für verbesserte absorption

Country Status (17)

Country Link
US (1) US20070298096A1 (de)
EP (1) EP1807068B1 (de)
JP (1) JP2008518914A (de)
CN (1) CN101048155A (de)
AR (1) AR051145A1 (de)
AT (1) ATE460930T1 (de)
AU (1) AU2005302618B2 (de)
BR (1) BRPI0520000A2 (de)
CA (1) CA2583517C (de)
DE (1) DE602005020048D1 (de)
MX (1) MX2007005121A (de)
NO (1) NO20072255L (de)
PE (1) PE20061125A1 (de)
PL (1) PL1807068T3 (de)
PT (1) PT1807068E (de)
RU (1) RU2398571C2 (de)
WO (1) WO2006049978A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0607085D0 (en) * 2006-04-07 2006-05-17 Smithkline Beecham Corp Novel compositions
CN100417385C (zh) * 2006-09-26 2008-09-10 林星 一种用于治疗外伤的外用制剂
GB0707489D0 (en) * 2007-04-18 2007-05-23 Renaissance Pharma Compounds
CN101596163B (zh) * 2008-06-06 2012-06-27 康美保宁（四川）制药有限公司 阿咖酚微丸制剂及其制备方法
GB0813929D0 (en) * 2008-07-30 2008-09-03 Glaxo Group Ltd Novel method
CN102861040B (zh) * 2012-08-02 2014-04-23 广东环球制药有限公司 含有阿司匹林、对乙酰氨基酚和咖啡因的药物组合物及其制备方法
CN102949401A (zh) * 2012-09-06 2013-03-06 广东九明制药有限公司 对乙酰氨基酚、乙酰水杨酸和咖啡因组合物及其制备工艺
US10124005B1 (en) * 2017-12-15 2018-11-13 Lisa Josette Myslinski Multisymptom migraine combination medication
CN110711197B (zh) * 2018-07-12 2023-11-24 北京恒润泰生医药科技有限公司 阿司匹林和对乙酰氨基酚的分子复合物加咖啡因,其制备,活性及应用
CN108853124A (zh) * 2018-08-15 2018-11-23 康美保宁（四川）制药有限公司 一种阿咖酚制剂及其制剂方法
GB202007670D0 (en) * 2020-05-22 2020-07-08 Glaxosmithkline Consumer Healthcare Holdings Us Llc Pharmaceutical composition

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294819A (en) * 1980-08-18 1981-10-13 Bristol-Myers Company Alkaline analgesic capsule
CA1182049A (en) * 1981-07-13 1985-02-05 Francis J. Sterbenz Apap antacid composition
US5296241A (en) * 1991-04-03 1994-03-22 Brimberg Barnett J Therapeutic composition and method of using same for treatment of hangover
JP3122748B2 (ja) * 1991-11-29 2001-01-09 ライオン株式会社 イブプロフェン含有解熱鎮痛剤
JP3172749B2 (ja) * 1992-02-17 2001-06-04 ライオン株式会社 イブプロフェン含有製剤
JPH06227995A (ja) * 1993-02-03 1994-08-16 Takeda Chem Ind Ltd 安定化された固型製剤
JPH07206689A (ja) * 1994-01-21 1995-08-08 Barnett Lab Ltd 治療組成物および宿酔の治療のためのこの組成物の使用法
DE19502789A1 (de) * 1995-01-28 1996-08-01 Dirk Krischenowski Arzneimittel
GB9704524D0 (en) * 1997-03-05 1997-04-23 Smithkline Beecham Plc Composition
US5972916A (en) * 1997-07-14 1999-10-26 Bristol-Myers Squibb Company Compositions containing the nonprescription combination of acetaminophen, aspirin and caffeine to alleviate the pain and symptoms of migraine
JP2002012557A (ja) * 2000-06-28 2002-01-15 Lion Corp 内服薬組成物
JP4365107B2 (ja) * 2001-05-25 2009-11-18 エスエス製薬株式会社 医薬組成物
JP4553552B2 (ja) * 2003-01-08 2010-09-29 日東薬品工業株式会社 生体リズム応用キット

Also Published As

Publication number Publication date
CN101048155A (zh) 2007-10-03
EP1807068B1 (de) 2010-03-17
RU2007119641A (ru) 2008-12-10
RU2398571C2 (ru) 2010-09-10
CA2583517A1 (en) 2006-05-11
NO20072255L (no) 2007-07-18
MX2007005121A (es) 2007-06-22
JP2008518914A (ja) 2008-06-05
US20070298096A1 (en) 2007-12-27
EP1807068A1 (de) 2007-07-18
AR051145A1 (es) 2006-12-20
AU2005302618B2 (en) 2009-10-22
CA2583517C (en) 2013-06-04
AU2005302618A1 (en) 2006-05-11
PE20061125A1 (es) 2006-11-08
WO2006049978A1 (en) 2006-05-11
PL1807068T3 (pl) 2010-08-31
DE602005020048D1 (de) 2010-04-29
PT1807068E (pt) 2010-04-19
BRPI0520000A2 (pt) 2009-04-07

Similar Documents

Publication Publication Date Title
ATE460930T1 (de) Zusammensetzung mit acetaminophen, koffein und aspirin zusammen mit einem alkaliwirkstoff für verbesserte absorption
LTC1763368I2 (lt) Deriniai, apimantys antimuskarininius agentus ir beta-adrenerginius agonistus
EP1924649A4 (de) Elektrolyt, umfassend eine eutektische mischung, und elektrochemische vorrichtung damit
SI1846445T1 (sl) PYY-agonisti in uporaba le-teh
ATE482618T1 (de) Wirkstoffkombinationen
ATE484194T1 (de) Wirkstoffkombinationen
BRPI0722081A2 (pt) Complexo metálico, composto polimérico e dispositivo contendo os mesmos
DE602005025460D1 (de) Teilchenförmiges wasserabsorptionsmittel mit unregelmässiger pulverform
BRPI0614205A2 (pt) composto, composição farmacêutica, e, uso de composto
BRPI0615900A2 (pt) granulados de enzima, uso de um granulado de enzima, e, ração
DE602006002137D1 (de) Mikroplättchengrosse Abdeckungskappe und deren Anfertigung
DK1907561T3 (da) Cellelinjer til ekspression af enzym, der er anvendeligt i fremstillingen af amiderede produkter
ATE419193T1 (de) Verschlusskappe
EP1790336A4 (de) Zusammensetzung für kapselfilm, kapselfilm und damit hergestellte kapsel
IL176408A (en) Electrochemical nitrate destruction
PT1954669E (pt) Feniletilaminas substituídas com actividade serotoninérgica e/ou norepinefrinérgica
BRPI0513872A (pt) composição polimérica, e, artigo conformado
DE602005022287D1 (de) Bleibatterie und bleibatterie-speicherverfahren
DE602005009081D1 (de) Dynamische Speicherkonfigurierung
EP1889324A4 (de) Funktionale elektrolytzusatzstoffe und elektrochemische einrichtung damit
TWI367091B (en) Sedative effect-enabling agent and sedative aroma composition comprising the same
DE602005024592D1 (de) Verdickung für eine alkalibatterie und alkalibatterie
BRPI0614413A2 (pt) composto, e, composição farmacêutica
BRPI0614412A2 (pt) composto, e, composição farmacêutica
EP1874294A4 (de) Benzothiophen-hydroxamidsäurederivate mit carbamat-, harnstoff-, amid- und sulfonamidsubstitutionen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties